Dipharma is delighted to be featured in the 2023 edition of Global Business Reports (GBR)’s USA Life Sciences digital report.
Read the interview with our colleagues Andrea Confetti, Exclusive Synthesis Business Unit Leader, and Roberto Fanelli, Catalogue APIs Business Unit Deputy Manager, to learn more about Dipharma’s product portfolio and how our Company is growing by diversifying the offer into Exclusive Synthesis and Catalogue APIs: https://projects.gbreports.com/united-states-life-sciences-2023/dipharma-francis-interview
For more information
Paola Clerici
Communication Manager
DIPHARMA FRANCIS S.r.l.
paola.clerici@dipharma.com
